Slide 1: First Quarter 2025 Earnings
Click Here to Edit Title First Quarter 2025 Earnings May 1, 2025
Slide 2: Cautionary Statement
Cautionary Click Here to Statement Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements ma
Slide 3: IDEX 1Q25 Highlights
IDEX 1Q25toHighlights Click Here Edit Title Built backlog across all three segments Experienced steady industrial day rates Delivered targeted growth wins and industrial channel automation and digitization benefits Furthered platform optimization and delayering efforts Deployed $50M capital to share
Slide 4: Q1 2025 Financial Performance
Q1 Click 2025 Here Financial to Edit Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* -1% Organic* -50 bps -7% -33% $814 26.0% 25.5% $1.88 $801 $1.75 $137 $91 Q1'24 Q1'25 Q1'24 Q1'25 Q1'24 Q1'25 Q1'24 Q1'25 Organic* FX M&A Y/Y ∆ Sales Growth -1% -1% 4%
Slide 5: Q1 2025 Adjusted EBITDA Walk
Q1 Click 2025 Here Adjusted to Edit Title EBITDA Walk ($ in millions) $208 6 1 3 $208 (2) (8) 1Q'24 ACT * Volume Net Price / Mix Variable Comp Acq / Div / FX 1Q'25 ACT * Adj EBITDA Flow Thru Productivity Adj EBITDA Flow thru @ Organic flow Total flow PY GM%* thru** through 45.0% (39%) (2%) **Exclude
Slide 6: Q1 2025: Health & Science Technologies
Q1 Click 2025: HereHealth to Edit&Title Science Technologies ($ in millions) Highlights Orders Sales Adj. EBITDA Margin* • Strong targeted growth wins across +3% Organic* -1% Organic* -60 bps space and energy transition • Analytical Instrumentation steady with 26.2% 25.6% trend towards LSD growth $3
Slide 7: Q1 2025: Fluid & Metering Technologies
Q1 Click 2025: HereFluid to Edit & Metering Title Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights • Continued strength in Municipal Water -3% Organic* -4% Organic* -80 bps and downstream energy markets • Stable industrial day rates $314 $314 33.6% 32.8% $295 $291 • Near-term
Slide 8: Q1 2025: Fire & Safety / Diversified Products
Q1 Click 2025: HereFire to Edit & Safety Title / Diversified Products ($ in millions) Highlights Orders Sales Adj. EBITDA Margin* • Fire and Safety seeing strong NA +2% Organic* +5% Organic* +50 bps Fire OEM and integrated solutions demand $178 $184 29.4% • Dispensing building on leadership 28.9% $1
Slide 9: 2025 Guidance Summary
2025 Click Here Guidance to Edit Summary Title Full Year Second Quarter Current Guidance Current Guidance Organic Revenue % vs Prior Year* 1% - 3% 0% - 2% Adjusted EBITDA %* 27.5% – 28.0% 26.5% – 27.0% Reported Earnings Per Share $6.56 - $6.95 $1.60 - $1.72 Adjusted Earnings Per Share* $8.10 - $8.45
Slide 10: Implications of Tariff Impact and IDEX Current Tariff Exposures
Implications Click Tariff Here Impact of Edit to and IDEXCurrent TitleTariff Exposures Advantage IDEX is Advantaged (1) Annualized Tariff Estimates to Manage Tariff Impacts • Tariff induced pricing actions adding 3-4% to China ~$80M sales on an annualized basis European Union ~$5M • Tariff-related i
Slide 11: Deliver Differentiated Growth and Earnings Through Scaled Strategic Growth Platforms
Deliver Differentiated Growth Click Here to Edit Title and Earnings Through Scaled Strategic Growth Platforms SCALED STRATEGIC GROWTH PLATFORMS REPRESENT MORE THAN 50% OF IDEX Material Sciences Life Sciences Severe Duty Flow Intelligent Water Fire & Safety Solutions Control Leading-edge portfolio of
Slide 12: Flexible and Opportunistic Capital Deployment
Flexible Click Here andtoOpportunistic Edit Title Capital Deployment Investing in Organic and Returning Capital Acquisitive Growth to Shareholders • Focusing on top organic investments • Financial and strategic flexibility afforded by strong cash generation and balance sheet • Cultivating bolt-ons i
Slide 13: IDEX Value Drivers
IDEXHere Click ValuetoDrivers Edit Title ORGANIC INORGANIC MARGIN GROWTH GROWTH EXPANSION • Leading market entitlement • Strong funnel of M&A opportunities • Leading the IDEX Op Model • Pricing execution • Fast growing companies • 80/20 • Growth bets prioritization • Disciplined capital deployment •
Slide 14: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 15: Table 1: Reconciliations of the Change in Net Sales to Organic Sales
Table 1: Reconciliations of the Change in Net Sales to Organic Sales FMT HST FSDP IDEX Three Months Ended March 31, 2025 Change in net sales (7%) 10% 4% 2% Less: Net impact from acquisitions/divestitures(1) (2%) 12% —% 4% (2) Impact from foreign currency (1%) (1%) (1%) (1%) Change in organic sales (
Slide 16: Table 4: Reconciliations of Net Income to Adjusted EBITDA
Table 4: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) Three Months Ended March 31, 2025 2024 Reported net income $ 95.4 $ 121.3 Provision for income taxes 29.1 33.2 Interest expense - net 16.1 9.4 Depreciation 18.4 16.2 Amortization 31.5 24.6 Fair value inventory step-up ch
Slide 17: Table 6: Reconciliation of Estimated 2025 Change in Net Sales to Change in Organic Sales
Table 6: Reconciliation of Estimated 2025 Change in Net Sales to Change in Organic Sales Guidance Second Quarter 2025 Full Year 2025 Low End High End Low End High End Estimated change in net sales 6% 8% 4% 6% Less: Net impact from acquisitions/divestitures(1) 6% 6% 3% 3% (2) Impact from foreign curr